Can Denmark’s world-beating drugs maker stay ahead?
Thanks to its weight loss drug, Novo Nordisk briefly became Europe’s most valuable firm in 2023.
Similar Posts
Sleep tracking going too far? You might be suffering from this condition, expert says
The duration and quality of sleep are both essential to overall health, experts agree — but when does a focus on getting a good night’s sleep turn into a harmful fixation? For some people, checking the data on their wearable sleep trackers can lead to a condition called “orthosomnia,” a name the Journal of Clinical…
Some nurses experience violent attacks at Seattle Children’s Hospital, say they want protection, support
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
If You Can Only Exercise On Weekends, That’s Still Great For Your Health, A Study Suggests
The “weekend warrior” exercise pattern once dismissed by experts as not quite good enough may not be so bad after all. A study in this week’s JAMA Network Open finds that people who walk 8,000 or more steps a day once or twice a week achieve cardiovascular benefits and lower mortality rates that are almost…
What It’s Really Like To Get Fillers And Implants Removed, According To Plastic Surgeons
With all the changes in cosmetic surgery trends — from lip injections to implants and filler removal — we asked plastic surgeons about the process of dissolving fillers and whether there are any risks associated with the reversals that are making headlines. This is what experts recommend that people know before getting procedures so that…
Is your Christmas tree causing allergies? What experts say about
‘Tis the season for sneezing and coughing — but in some cases, it may not be seasonal germs but the Christmas tree in your living room that’s making you feel those symptoms. Sometimes referred to as “Christmas Tree Syndrome,” experts say it can cause your indoor allergies to flare up around the holiday. It’s not an…
Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…
